ArticleCancer2022

Association between timely targeted treatment and outcomes in patients with metastatic HER2-overexpressing gastroesophageal adenocarcinoma.

Kelsey S Lau-Min et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.